Get started

Value

JSW Cement: Company Profile & Sector Analysis 🙀🧐Conclusion 🧐🙀 🤔While JSW Cement demonstrates ambition and operational scale in India’s vibrant cement sector, its financial health is tempered by high leverage and modest returns. Strong governance, strategic debt management, and transparent reporting will be critical as the company seeks market leadership among robust peers. Long-term investors should closely monitor improvements in cash flows and efficiency, given sector opportunities and competitive dynamics. 🧐The cement sector shows strong growth led by robust leaders; JSW Cement is a promising but highly leveraged mid-cap facing profitability and liquidity challenges. Sector fundamentals remain resilient, but JSW’s turnaround depends on prudent financial and governance reforms 🌺🌺About JSW Cement🌺🌺 JSW Cement is a prominent Indian cement manufacturer, recently listed on BSE and NSE in August 2025. The company aims to rapidly expand its production capacity and footprint across key markets with a focus on sustainable manufacturing and innovative processes. 🤯Cement Sector Growth & Future Potential🤯 - India’s cement demand driven by government infrastructure push and urbanization. - Sector CAGR expected at 7-9% over the next five years with rapid capacity additions. - Companies investing in green cement, alternative fuels, and digital operations. - Consolidation and entry of large players signal a highly competitive future market landscape. 🧐Financials Snapshot (FY25)🧐 - Revenue: ₹6,028 crore - Operating Margin: 15.3% - EBITDA Margin: 16% - Net Margin: 1% - Market Cap: ₹7,400 crore - Free Cash Flow: Negative 😶‍🌫️Key Ratios😶‍🌫️ - Debt/Equity Ratio: 2.6 (sector high) - Return on Equity (ROE): 0.6% (below industry average) - Return on Capital Employed (ROCE): 8% - Current Ratio: 0.65 - Dividend Payout: 0% 👷🏻 Peer Analysis👷🏻 - UltraTech Cement, Shree Cement, and Ambuja Cement lead with stronger margins and lower debt. - JSW Cement’s leverage (high debt) impacts profitability and shareholder returns. - Sector leaders maintain ROE and ROCE above 10-13%; JSW lags in these metrics. - Free cash flow in JSW Cement lags behind top peers due to high investment and operational pressures. - Margins are competitive but net profitability is limited compared to industry best. - JSW Cement is positioned as a mid-cap, growth-oriented player with room for efficiency improvement. - Company’s focus on expansion adds long-term growth potential. - Peer companies show higher liquidity and sustainable dividend payout records.
NSE:JSWCEMENT
by Tap_trader
Bitcoin’s Power Law Curve — Fairly Valued With Room to RunThis chart applies a Power Law Rainbow Model to Bitcoin using a long-term logarithmic regression fitted to BTC's historical price action. Power laws are mathematical relationships often found in nature, science, and network systems — and Bitcoin is no exception. Rather than relying on arbitrary trendlines, this model fits a curve based on the equation: Price = a × t^b Where: t is the number of days since inception a and b are constants optimized to Bitcoin's growth Bands represent log-scaled standard deviation zones from the curve 🌈 Interpreting the Chart The center white curve reflects Bitcoin's "fair value" according to its adoption-based trajectory. Colored bands represent ±1σ, ±2σ, ±3σ from the model, creating a "valuation rainbow." Historically, Bitcoin's cycle bottoms have touched the lower bands (blue/purple), while euphoria tops align with the upper bands (orange/red). ✅ Current Outlook BTC is trading just under the fair value curve , suggesting it's fairly valued or slightly undervalued from a long-term perspective. This position has historically preceded major upside moves, especially in post-halving environments. From a Smart Money Concepts angle, we're in a potential accumulation or markup phase , with institutional and informed capital likely already positioning. 🧠 Why Power Laws Work for BTC Bitcoin adoption follows network effects — more users = more value — which naturally follows a power law. Unlike linear trends, power law curves scale with time , making them ideal for modeling exponential assets. They offer a more objective long-term valuation framework , avoiding emotional cycle chasing. ⚠️ Disclaimer This is not financial advice . The model reflects historical behavior and is a tool to support long-term perspective — not short-term prediction. Always do your own research and risk management.
INDEX:BTCUSD
by RWCS_LTD
HCA Healthcare | HCA | Long at $299.00NYSE:HCA Healthcare: P/E of 13x, earnings are forecast to grow 6.01% per year; earnings have grown 10.6% per year over the past 5 years, and trading at good value compared to peers and industry. From a technical analysis perspective, it dipped to my selected historical simple moving average area and may represent a buying opportunity to fill the daily price gap up to $394.00. Thus, NYSE:HCA is in a personal buy zone at $299.00. Target #1 = $324.00 Target #2 = $362.00 Target #3 = $394.00
NYSE:HCALong
by WorthlessViews
Lennar Corp | LEN | Long at $116.48Across the US, there is a pent-up demand for housing (for the vast majority of locations). While the media likes to selectively report home sales dropping for certain regions, it is more due to mortgage rates and seasonality than demand. Mortgage rates are anticipated to come down over the next 1-2 years and home builders will step in to pick-up the lack of inventory. Healthy companies like Lennar Corp NYSE:LEN , with a P/E of 8x, dividend of 1.68%, very low debt-to-equity (0.17x), etc are likely to prosper, but always stay cautious with the dreaded "recession" announcement if it creeps in... Thus, at $116.48, NYSE:LEN is in a personal buy-zone. In the near-term, I do see the potential for the price to dip near $100 as tariff and other economic red flags continue to be in focus. Targets: $131.00 $145.00 $157.00 $180.00
NYSE:LENLong
by WorthlessViews
Both Technical and Valuation Signals Points Incoming VolatilityThe DAX has been moving sideways since May, with this flat movement evolving into a triangle formation since June. Price action is contracting, and the index appears to be waiting for a catalyst to determine its next direction. The DAX is currently near the regression line from the November dip, which keeps both upward and downward possibilities open, consistent with the neutral signal from the triangle pattern. From a valuation perspective, the DAX’s forward P/E ratio stands at 16.95x, roughly one standard deviation above its 2009-to-date regression line, making it relatively expensive compared to its own history. The S&P 500 trades at a much higher forward P/E of 24.25x, but that figure is near its own long-term regression line. Since early June, the DAX/S&P 500 ratio has fallen by nearly 10%, significantly reducing the DAX’s relative overvaluation and potentially giving it room for another leg higher. Ultimately, the triangle formation may be the deciding factor. The current upper boundary is at 24,500, and the lower boundary is at 23,490. A break of either could bring volatility back to the DAX, with momentum likely to follow the breakout direction. An upward break could target the 24,400–24,500 zone.
PEPPERSTONE:GER40
by ftdsystem
GENIUS Act Spurs Corporate Stablecoin Ambitions Amid Legal HurdlThe newly enacted GENIUS Act has created a landmark regulatory framework for stablecoins in the United States. The law mandates 1:1 backing, rigorous audits, and full transparency for issuers, effectively opening the door for large-scale corporate entry into the sector. Major corporations — including top banks, retail giants, and global tech firms — are now exploring the launch of their own dollar-backed digital tokens. Others are considering strategic partnerships with established issuers to accelerate their entry into the market. The potential applications range from global remittances to supply chain finance, with the promise of faster settlement, lower fees, and improved liquidity. However, significant challenges remain. The regulatory rollout will be phased and compliance-heavy, requiring ongoing coordination with multiple federal agencies. Businesses must also decide whether to operate on public blockchains like Ethereum or Solana, or develop private networks for greater operational control and security. The stablecoin market is expected to expand rapidly under the new law, but issuers must navigate complex issues around anti-money laundering controls, customer identity verification, and capital reserve management. Striking the right balance between regulatory compliance and market competitiveness will be crucial. Meanwhile, established stablecoin providers are adjusting their strategies to align with the new rules, focusing on building institutional trust while maintaining product scalability. For new entrants, the GENIUS Act represents both an opportunity and a challenge — those who move quickly yet carefully may secure a decisive advantage. As the stablecoin infrastructure matures, regulated token issuance by reputable corporations could drive the next wave of crypto integration into mainstream finance. The companies that master compliance, security, and utility will be the ones to define this new era in digital currency.
CRYPTOCAP:USDCLong
by HCN-News12
1.80 this week Posting this chart to show some obvious short term levels if your trading this is I was lucky enough to get Jan 26 1C for .21. I think TLRY could run to 2 pretty easily based on current momentum. Trump said he was looking into declassification when asked today and has shown support before for rescheduling, decriminalization, and state rights to legalize cannabis. "It could take a few weeks and is very complicated." he said I grabbed safer calls to far out although 100% gain today. The closer dated 1.5 calls are cheap and ran 3x as hard ill be looking to load some tm if chart remains above daily MAs. IF weed actually somehow gets declassified $3 should be easy. Up at $1.09-1.16 overnight would be bullish to hold $1 for entry. 4hr RSI is at 90 so this meme like rally could end abruptly or maybe it wants 1.50 first. Revenue has steadily been growing nothing crazy still not profitable and they have been diluting Gross margin is 29.49%, with operating and profit margins of -13.04% and -266.25%. Plenty of risk 17% short float.
NASDAQ:TLRYLong
by WSMS199
2
Evolent Health | EVH | Long at $9.45While 2025 is expected, and has been, a bad year for Evolent Heath NYSE:EVH , the growth prospects look very, very promising. However, I will caution that the price could almost be cut in half from its current trading value ($9.45) with another poor earnings in 2025. This definitely isn't an "it's only up from here" stock. The price entered my "crash" simple moving area (green lines) twice and a third time could occur before the end of the year ($4-$5 range as of this writeup). Regardless of bottom predictions, earnings for NYSE:EVH are expected to rise from $1.9 billion in 2025 to $3.2 billion in 2028. EPS predicted to rise from $0.26 in 2025 to $1.18 in 2028. Debt-to-equity = 1.2x (okay, below 1 is best), Quick Ratio, or the ability to pays current bills is = 1x (okay, between 1.5 and 3 is best), and bankruptcy risk is relatively high (but reduced interest rates may help). Insiders have purchased over $11 million in shares this year with a cost average (~$23): much higher than it's current trading price. So, while it seems there could be some short-term risks for Evolent Health, the future beyond 2025 is bright (based on company projections). Thus, at $9.45, NYSE:EVH is in a personal buy zone with potential downside risk near $4-5 in the near-term. Targets into 2028: $15.00 (+58.7%) $20.00 (+111.6%)
NYSE:EVHLong
by WorthlessViews
FlySBS Aviations –" Next decade "NSE:FLYSBS 🫰🏻 CONCLUSION 🫰🏻 With strong sector tailwinds, rapid fleet expansion, and clear operational scale-up plans, FlySBS Aviation is well positioned to deliver sustainable positive cash flows and attractive long-term returns, offering meaningful upside for investors as industry demand accelerates 🌸 Company Overview & Industry 🌸 -FlySBS Aviation is a private non-scheduled air charter operator serving B2B & B2C clients including corporates, HNIs, celebrities, and diplomats. -Operates a fleet of 3 owned private jets plus dry/wet lease options to meet demand surges. -The Indian private aviation market is growing rapidly, with an expected CAGR of 8–15% over the next decade 🌸FY2025 Sales (Total Revenue: ₹193.9 Cr)🌸 Private Jet Charters: 94% (₹182 Cr) International Missions: 77% (₹149 Cr) Domestic Charters: 23% (₹44.7 Cr) Medical/Security Operations: 4% (₹8 Cr) Subscription/Leasing: 2% (₹3 Cr) 🌸Financial Highlights (FY21–25)🌸 Revenue CAGR: ~63% Net Profit CAGR: ~70% Operating Margin: 21% Net Profit Margin: 14.7% ROE: 18.9% EPS (FY25): ₹25.47 🌸DCF Valuation Insight🌸🫰🏻 Intrinsic Value: ~₹220 per share Justification: The valuation captures the expected transition from a heavy investment phase with negative free cash flow toward stable and positive cash flow generation. The reliability is moderate, contingent on effective execution of growth plans and capital management aligned with market trends
NSE:FLYSBS
by Tap_trader
Ironwood Pharmaceuticals | IRWD | Long at $0.61Ironwood Pharma NASDAQ:IRWD stock dropped ~89% in the past year due to disappointing Phase 3 Apraglutide trial results, FDA requiring an additional trial, weak Q1 2025 earnings (-$0.14 EPS vs. -$0.04 expected), high debt ($599.48M), and analyst downgrades. So why would I be interested in swing trading this company? The chart. The price has entered my "crash" simple moving average zone, which often results in a reversal - even if temporary. Also, Linzess (GI drug) revenue is steady, and I thoroughly believe that alone pushes the fair value near $0.95, if not higher. Thus, at $0.61, NASDAQ:IRWD is in a personal buy zone with the potential for additional declines before future rise. Target: $0.95 (+55.7%)
NASDAQ:IRWDLong
by WorthlessViews
NSDL (INTRESTING STOCK )👉🏻 NSDL – Equity Snapshot 👈🏻 🕛 Conclusion ⏱️ NSDL stands at a strategic inflection point — evolving from an institutionally heavy, legacy infrastructure provider to a retail and digitally agile depository. With a zero-debt model, strong cash flows, and clear retail growth plans underway, NSDL shows potential for steady earnings expansion and margin improvement over the next few years. The foundation is strong; execution will now drive the delta. 🙋🏻 Introduction India’s largest depository by value, with over ₹450 lakh crore in Assets Under Custody (AUC). Founded in 1996, primarily serving institutional and corporate clients. Known for stability, trust, and core infrastructure services in the capital market. 🌸 Financial Performance (FY25)🌸 Total Revenue: ₹1,535 crore. Depository Business Revenue: ₹660 crore (Approx. 43% share). Operating Margin (Core Business): ~50%. Net Margin: 22% – 24%. Net Profit: ₹330+ crore. Free Cash Flow: ₹558 crore+. Debt: Zero (Fully debt-free). Capital Expenditure: ~₹74 crore only (Low capex model). 🌸 Market Position🌸 Dominates in value terms (highest AUC in India). Client base includes mutual funds, banks, insurers, and corporates. Retail demat accounts: ~4 crore (behind CDSL’s 15+ crore). High average demat account size (~₹1,100 crore) vs CDSL’s retail-heavy base. Gaining ground in retail via partnerships with Zerodha, Groww, Angel One, etc. 🌸 Future Growth Focus🌸 Aggressively entering retail segment through schemes like ‘YUVA Plan’. Enabling paperless, digital onboarding for faster account growth. Investing in blockchain, T+1 settlements, and smart compliance tools. Actively participating in SEBI & RBI-led digitization (e-KYC, e-insurance, GIFT city). Expanding subsidiaries (NDML, NPBL) to boost recurring income beyond core biz. 🌸 Key Positives🌸 Strong free cash flow, high annuity-based revenue visibility. Lean, tech-driven operations with low employee cost base. Well-positioned to benefit from India’s growing retail investor base. Diversified, recurring revenue streams through subsidiaries. Digital-first strategy ensures scalable, low-cost growth ahead.
BSE:NSDLLong
by Tap_trader
JELD-WEN Holdings | JELD | Long at $4.02JELD-WEN Holdings NYSE:JELD designs, manufactures, and sells wood, metal, and composite materials doors, windows, and related building products in North America and Europe. The stock has taken quite a beating since the rise in interest rates, and I think a reversal *may* be in sight in the next year as rates are slowly lowered - even if the market is forward-thinking and purely anticipating a new housing boom (which I highly doubt given the current home prices). Regardless, there is risk with this stock since it has relatively high debt (debt-to-equity of 2.61x). A Quick Ratio of 1.1 and Altman's Z Score of 1.9 puts NYSE:JELD near a medium level of bankruptcy risk. The company has pretty good cash reserves and a forward P/E of 10x (current is negative), so growth is anticipated. Book value of $5.31. A bear case here is a terrible earnings call in August 2025 due to the housing market slowing (i.e. people pausing home purchases/builds/repairs expecting interest rates to drop soon). That may plummet the stock near $1.00 or below, which would be a tremendous deal, *unless* the company fundamentals change (like bankruptcy). Without a crystal ball, yet understanding the forward-thinking aspects of the market, NYSE:JELD is in a personal buy-zone at $4.02 with some risks. Targets into 2027: $5.40 (+34.3%) $8.50 (+111.4%)
NYSE:JELDLong
by WorthlessViews
Charter Communications (Revised) | CHTR | Long at $269.50 **This is a revised analysis from December 26, 2024: . My stop was triggered in that original trade after the recent price drop (some gains were taken at 13%, as noted).** Charter Communications NASDAQ:CHTR stock recently dropped due to a disappointing Q2 2025 earnings report, with earnings per share of $9.18 missing estimates of $9.58 and a larger-than-expected loss of 111,000 residential internet customers. Despite the recent subscriber losses and increased competition, the following factors suggest long-term growth potential: Network Expansion: Launch of 2x1 Gbps service in eight markets in 2025, boosting competitiveness. Rural Growth: Rural revenue projected to reach 10–15% of total revenue by 2025. Cox Acquisition: $34.5B merger expected to close by mid-2026, yielding $500M in annual cost savings by 2028 and enhancing market share. Mobile and AI Strategies: Strong mobile growth and AI-driven customer service tools to improve retention and efficiency. Lower Interest Rates: Reduced bowering costs to help with profit margins. Charter's President/CEO recently grabbed $2.5 million in shares under $300. From a technical analysis perspective, there is an open price gap near $195 that could be of concern in the near-term. I foresee that being closed if the whole market flips or more bad news for the company arises. But, with a P/E of 7x and the industry average being near 13x, I believe NASDAQ:CHTR is a good value at the moment. Thus, at $269.50, NASDAQ:CHTR is in a personal buy zone with a note of "risk" of a drop near $195 (a second personal entry point if it hits that level before targets are reached). Targets into 2028: $330.00 (+22.4%) $375.00 (+39.1%)
NASDAQ:CHTRLong
by WorthlessViews
1
Berkshire Hathaway looks appealing in todays market conditionsWith most markets at all time highs it is becoming increasingly difficult to find good opportunities for buying. I have decided to allocate about 9% of my portfolio to Berkshire Hathaway as a sort of hedge against some of my other positions. I like to have a diverse exposure to the markets and with Berkshire Hathaway being a conglomerate it is a perfect stock for someone like me to invest in. The stock seems to be doing the opposite of the us500 so far this year hence why I call it a hedge. According to my simple technical analysis there is a probability for the stock to make a reversal after spending some time going down. The company has already donated plenty of shares which probably has something to do with it going down, which presents a unique opportunity to invest in it since there is nothing fundamentally wrong with the company. With that being said they have also said they probably wont engage in share buy backs until next year at least so it could be a falling knife type situation. However I am confident in the company and feel like it is a great stock to have in my portfolio for the long term. The range of the intrinsic value according to the discounted cash flow model is between $400-$1000 with a 5 year exit. Assuming a 7.4% discount rate the intrinsic valuation for the stock is $575 presenting a unique opportunity for a 20% upside. The stock is certainly undervalued but like I said it could be a falling knife in the worst case scenario. Calculating the intrinsic value is highly speculative and complex, but it gives me increased confidence in my decision to push the buy button. I hope you found my analysis useful, drop a comment if you want to talk more about the stock or whatever.
NYSE:BRK.BLong
by Capitalist_Zach
2
DCF VALUATION ANALYSIS OF BSEConclusion: OVERVALUED :-OVERVIEW BSE Limited has shown strong financial growth in recent years. Its revenue jumped from ₹924.84 crore in FY23 to ₹1,592.50 crore in FY24 (a 72% increase), and further surged to ₹3,212 crore in FY25, doubling year-on-year. EBITDA grew impressively to ₹1,779 crore in FY25 with a 60% increase, and EBIT reached ₹1,670 crore, up 56%. Net profit also rose significantly to ₹1,112 crore, with earnings per share increasing to ₹81. Dividend per share improved to ₹23, reflecting healthy returns DCF: -The valuation was performed using a Discounted Cash Flow (DCF) approach based purely on verified financial data and market risk parameters without relying on user-specific growth assumptions. -The cost of equity was calculated using an adjusted risk-free rate plus equity risk premium multiplied by beta, resulting in a discount rate of approximately 13.58%. The terminal growth rate was conservatively taken as 4%. Using these reliable inputs and actual EBIT cash flows, the intrinsic enterprise value was estimated at around ₹36,839 crore, translating to an intrinsic value per share of approximately ₹1,364. -Currently, BSE’s market price is around ₹2,480 per share, which is substantially higher than the intrinsic value derived from fundamentals, indicating the stock is trading at a significant premium. This valuation is grounded in audited company financials and globally accepted valuation methodologies, providing a trustworthy reference point for investors.
NSE:BSEShort
by Tap_trader
4